Steven Wheen

Stock Analyst at Jarden

(4.02)
# 1,737
Out of 5,078 analysts
246
Total ratings
47.8%
Success rate
8.9%
Average return

Stocks Rated by Steven Wheen

Telix Pharmaceuticals Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $21.00
Current: $12.95
Upside: +62.16%
Healius Limited
Sep 28, 2026
Reiterated: Hold
Price Target: $0.50 → $0.54
Current: $0.44
Upside: +22.73%
Regis Healthcare Limited
Sep 3, 2026
Reiterated: Hold
Price Target: $7.50 → $6.20
Current: $4.77
Upside: +29.98%
Ramsay Health Care Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $47.60 → $53.00
Current: $54.84
Upside: -3.36%
Integral Diagnostics Limited
Aug 26, 2026
Reiterated: Buy
Price Target: $3.25 → $2.95
Current: $2.10
Upside: +40.48%
Sonic Healthcare Limited
Aug 21, 2026
Reiterated: Hold
Price Target: $22.30 → $22.90
Current: $19.08
Upside: +20.02%
Cochlear Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $169.00 → $165.00
Current: $142.70
Upside: +15.63%
CSL Limited
Aug 19, 2026
Upgraded: Buy
Price Target: $191.00 → $207.00
Current: $193.06
Upside: +7.22%
ResMed Inc.
Aug 10, 2026
Reiterated: Buy
Price Target: $40.20 → $39.90
Current: $36.03
Upside: +10.76%
QBE Insurance Group Limited
Feb 20, 2026
Reiterated: Hold
Price Target: $22.00
Current: $26.38
Upside: -16.59%
Reiterated: Hold
Price Target: $0.71 → $0.75
Current: $0.52
Upside: n/a